Matthew Calistri | IR |
Dr. Jeff Jonas | CEO |
Mike Cloonan | Chief Business Officer |
Kimi Iguchi | CFO |
Dr. Steve Kanes | Chief Medical Officer |
Dr. Jim Doherty | Chief Research Officer |
Cory Kasimov | J.P. Morgan |
Tazeen Ahmad | Bank of America |
Salveen Richter | Goldman Sachs |
Paul Matteis | Stifel |
Andrew Tsai | Jefferies |
Laura Chico | Wedbush Securities |
Ritu Baral | Cowen |
Akash Tewari | Wolfe Research |
Danielle Brill | Piper Sandler |
Max Skor | Morgan Stanley |
Brian Abrahams | RBC Capital Markets |
Gary Nachman | BMO Capital Markets |
Rudy Li | SVB Leerink |
Yatin Suneja | Guggenheim |
Jay Olson | Oppenheimer |
Vamil Divan | Mizuho |
Lachlan Hanbury-Brown | William Blair |
Sumant Kulkarni | Canaccord |
Good morning. Welcome to Sage Therapeutics Fourth Quarter and Year-End 2019 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com.
This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited.